Category: Health Science
-
Biohaven (BHVN.NYSE), Zosano Pharma (ZSAN.Q), Lundbeck (HLUYY.OTC) tackle a $41 billion problem that cruelly targets women
“More than 4 million adults experience chronic daily migraine – with at least 15 migraine days per month,” states The Migraine Research Foundation, “It affects 39 million people in the U.S. and 1 billion worldwide.”
-
The market is up, but it’s all theatre: Don’t let The Fed’s buying suck you in
Trust me, there’s nothing I’d like more, as the publisher of a financial markets-focused media outlet, than to tell you all it’s time to buy back in on these ailing markets. I’ve got clients who’d reward me well if I were to convince you that it’d be a good idea to buy their stock in…
-
Revive Therapeutics (RVV.C) finds pharma asset under the couch that may treat COVID-19
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
-
NMC Health (NMHLY.OTC) gets sued – stock surges 90% anyway
Last week, NMC admitted that it identified an additional $2.7 billion in debt, rounding the total debt to around $5 billion. NMC staff were not paid last month.
-
![Did Aytu BioScience (AYTU.Q) just SpankChain the NASDAQ?]()
Did Aytu BioScience (AYTU.Q) just SpankChain the NASDAQ?
When a sector gets hot, small cap stocks can often get a bump by sidling up to the hot sector with a new product/idea/opportunity. When the dust clears, the intrinsic value of the new offering is typically deemed to be low. We saw it in 3D-printing, with Dung Beetle Treats. We saw it in weed…
-
AMPD, PAT, MTA, HIVE, MILE: Contrarian investing as the zombies climb over the walls
Okay, so the world is burning, the Russians and Saudis are pouring low-cost fuel over it, the Americans are shocked that a reality TV show host with a penchant for scams didn’t make a clever President, Italy is in total lockdown, the Japanese are thinking of holding a spectator-free Olympics, Israel is putting anyone coming…
-
Shroom stocks go nuts: First movers SHRM, MMED, RVV up hard as gamblers gamble
Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who’d listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O’Leary were on…
-
![CloudMD (DOC.C): Perhaps this might be a good time to talk about investing in telemedicine]()
CloudMD (DOC.C): Perhaps this might be a good time to talk about investing in telemedicine
As happens whenever a global crisis hits, there are plenty of investors currently watching the global Coronavirus outbreak and looking to panic sell. There are also a few looking to capitalize on the opportunities found in potential doom. Like folks who buy gun stocks whenever a military conflict breaks out, or those who buy gold…
-
Moderna’s (MRNA.Q) “Coronavirus Vaccine” announcement – causes $3.4 billion jump in market cap
We’ll take a wild guess that precisely NONE of the retail investors who just drove up the price of the MRNA would recognise a “stabilized form of S protein” if they met it on a beach, made sand castles with it – then took it home to play Spin-The-Bottle.
-
![2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed]()
2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed
Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they…
